Use of pyruvylglycine to treat ischemia/reperfusion injury following myocardial infarction
AssigneeAbbott Laboratories
InventorsRobert H. Miller, Mark A. McCamish, Ronald T. Stanko
Life of this patent
Estimating the term…
Abstract
A therapeutic method is provided to reduce ischemia/reperfusion injury to the heart muscle by perfusing pyruvylglycine into the circulatory system of a patient who has had a heart attack or suffered coronary occlusion.
Claims6
A method for treating ischemia/reperfusion injury of the coronary muscle, which method comprises administering a therapeutically effective amount of pyruvylglycine into the circulatory system.
A method for enhancing recovery of regional segment function in a stunned myocardium of a mammal following myocardial injury by parenterally administering a therapeutically effective amount of pyruvylglycine into the circulatory system.
A method for enhancing performance of regional segment function in an injured myocardium of a mammal by administering a therapeutically effective amount of pyruvylglycine.
Dependencies are inferred from the claim text.